What Keeps The Momentum Going in Catabasis Pharmaceuticals Inc. (CATB)?
Catabasis Pharmaceuticals Inc. (NASDAQ: CATB) was up 8% in extended hours on Monday thanks to an SEC filing. CATB stock’s year to date performance is 63.55%. A look at its 7-day chart indicates that it has dropped by -3.85% in the last seven days but is up 43.44% in the past month. Get the hottest […]